RESUMEN
The current study aimed at optimizing a previously developed non-clinical formulation for use in zolpidem deprescribing. The formulation under investigation consists of extruded zolpidem hemitartrate (30% w/w) and Eudragit EPO (70% w/w) mixtures which display unsatisfactory dissolution behavior. Both milled extrudates and physical mixtures were compressed to produce tablets with identical target weight and solid fraction. First, the susceptibility of zolpidem hemitartrate towards heat and shear degradation was identified utilizing thermal and HPLC-DAD analysis. The drug salt proved prone to thermally induced disproportionation. Moreover, the impurity content increased after applying hot melt extrusion although ICH guidelines were still attained. Secondly, extrudates and physical mixtures were subjected to FTIR analysis. As a result, interaction and protonation of the dimethyl aminoethyl group from Eudragit EPO resulting from zolpidem disproportionation was elucidated. As such, the formulations' slow dissolution kinetics in comparison to formulations containing non-ionizable polymers (e.g. Kollidon 12PF and Kollidon VA64) is explained. Finally, addition of tartaric acid, a microenvironmental pH modulator and common ion, proved a successful method to increase dissolution kinetics. The amount of drug released after 15 min increased drastically from 10 to 40% upon the addition of 5% tartaric acid. Immediate release behavior (80% within 15 min) was however not yet attained.
Asunto(s)
Química Farmacéutica , Calor , Zolpidem , Química Farmacéutica/métodos , Solubilidad , Composición de Medicamentos/métodosRESUMEN
Tumor necrosis factor alpha (TNF-alpha) plays a crucial role in the pathogenesis of the central nervous system infections. In an in vitro reconstructed blood-brain barrier model, a significant dysregulation of receptor mediated endocytosis of low density lipoproteins (LDL) and transferrin (Tf) is demonstrated at delayed phase of direct TNF-alpha activation. Concomitant with the increase in LDL uptake, we demonstrate a decrease of Tf-receptor mediated endocytosis. The potential role of TNF action in the differential or opposite routing of macromolecules is also characterized by a stimulation of their transcytosis. These findings may provide a new insight into the inflammatory effect of TNF-alpha on brain capillary endothelial cells.
Asunto(s)
Barrera Hematoencefálica/efectos de los fármacos , Circulación Cerebrovascular/efectos de los fármacos , Endocitosis/efectos de los fármacos , Endotelio Vascular/efectos de los fármacos , Receptores de Transferrina/fisiología , Factor de Necrosis Tumoral alfa/farmacología , Animales , Transporte Biológico , Capilares/citología , Capilares/efectos de los fármacos , Permeabilidad Capilar/efectos de los fármacos , Bovinos , Células Cultivadas , Citoesqueleto/efectos de los fármacos , Endotelio Vascular/citología , Inulina/farmacocinética , Lipoproteínas LDL/farmacocinética , Sustancias Macromoleculares , Ratas , Sacarosa/farmacocinéticaRESUMEN
The aim of this work was to assess the efficacy of oral N'Dribala (tuberous roots decoction of Cochlospermum planchonii Hook) treatment versus chloroquine in non-severe malaria. The study included 85 patients with uncomplicated Plasmodium falciparum infection in Banfora, Burkina Faso. Forty-six patients that received N'Dribala beverage were compared to 21 patients treated with chloroquine. All patients were monitored with clinical examination and a parasitemia control by Giemsa-stained thick films. N'Dribala appeared safe and statistically as efficient as chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria. At day 5 (D5), 57% of chloroquine-treated and 52% of N'Dribala-treated patients were cured with no detectable parasitemia (parasite density (Pd): 0) and more than 90% of whole patients were asymptomatic. N'Dribala is easily available in this country, cheap, without significant side effects and efficient with a clearly demonstrated activity on Plasmodium falciparum blood stages. This study enhances the traditional use of the Cochlospermum planchonii as alternative therapy for treatment of non-severe malaria.
Asunto(s)
Antimaláricos/uso terapéutico , Bixaceae , Cloroquina/uso terapéutico , Malaria Falciparum/tratamiento farmacológico , Fitoterapia , Adolescente , Adulto , Niño , Femenino , Humanos , Malaria Falciparum/parasitología , Masculino , Medicinas Tradicionales Africanas , Persona de Mediana Edad , Extractos Vegetales/uso terapéutico , Raíces de PlantasRESUMEN
The theory and technique of cylindrical osteotomy are described. It allows correction of angulation with some lengthening of the bone. It does not allow the correction of rotational deformities. 18 cases were operated on, 4 in the tibia and 14 in the femur.
Asunto(s)
Alargamiento Óseo/métodos , Diferencia de Longitud de las Piernas/cirugía , Osteotomía/métodos , Adolescente , Adulto , Placas Óseas , Tornillos Óseos , Niño , Preescolar , Femenino , Fémur/cirugía , Humanos , Masculino , Persona de Mediana Edad , Tibia/cirugíaRESUMEN
Five hundred and forty-four valgus osteotomies for medial compartment osteoarthritis of the knee have been performed by two teams working separately over a period of twenty years between 1964 and 1984. From this series the results of a technique which aims to combine precision of correction with stability of fixation have been assessed. The clinical results in the short and medium term are encouraging. Above all, it seems that improvement in the osteoarthritis can be maintained for ten years or more, that is to say greater than the mean expectation of life of the patients.
Asunto(s)
Osteoartritis/cirugía , Osteotomía/métodos , Tibia/cirugía , Adulto , Anciano , Femenino , Estudios de Seguimiento , Humanos , Articulación de la Rodilla/cirugía , Masculino , Persona de Mediana EdadAsunto(s)
Lesiones de Codo , Fracturas Óseas/complicaciones , Luxaciones Articulares/diagnóstico por imagen , Adolescente , Adulto , Niño , Femenino , Fijación de Fractura/métodos , Fracturas Óseas/terapia , Humanos , Luxaciones Articulares/complicaciones , Luxaciones Articulares/terapia , Masculino , RadiografíaAsunto(s)
Fracturas del Fémur/cirugía , Osteotomía/efectos adversos , Adolescente , Adulto , Femenino , Fémur/cirugía , Fijación de Fractura , Humanos , MasculinoAsunto(s)
Fémur/cirugía , Osteotomía , Fasciotomía , Femenino , Humanos , Ligamentos Articulares/cirugía , Matemática , Métodos , Persona de Mediana Edad , Músculos/cirugía , Cuidados Posoperatorios , SuturasRESUMEN
A cell culture model of the blood-brain barrier consisting of a coculture of bovine brain capillary endothelial cells (BBCECs) and astrocytes has been used to examine the mechanism of iron transport to the brain. Binding experiments showed that BBCECs express 35,000 high-affinity (concn at 50% receptor saturation = 11.3 +/- 2.1 nM) transferin (Tf) receptors per cell. In contrast to apo-transferrin (apoTf) we observed a specific transport of holo-transferrin (holoTf) across BBCECs. This transport was inhibited completely at low temperature. Moreover, the anti-Tf receptor antibody (OX-26) competitively inhibited holoTf uptake by BBCECs. Pulse-chase experiments demonstrated that only 10% of Tf was recycled to the luminal side of the cells, whereas the majority of Tf was transcytosed to the abluminal side; double-labeling experiments clearly demonstrated that iron crosses BBCECs bound to Tf. No intraendothelial degradation of Tf was observed, suggesting that the intraendothelial pathway through BBCECs bypasses the lysosomal compartment. These results clearly show that the iron-Tf complex is transcytosed across brain capillary endothelial cells by a receptor-mediated pathway without any degradation.
Asunto(s)
Barrera Hematoencefálica , Endotelio Vascular/metabolismo , Receptores de Transferrina/fisiología , Transferrina/farmacocinética , Animales , Astrocitos/metabolismo , Transporte Biológico/efectos de los fármacos , Capilares/citología , Capilares/metabolismo , Bovinos , Membrana Celular/metabolismo , Técnicas de Cocultivo , Endocitosis , Endotelio Vascular/citología , Hierro/farmacocinética , RatasRESUMEN
Tumor necrosis factor-alpha (TNF-alpha), a proinflammatory cytokine, has long been known to be involved in the pathogenesis of central nervous system infections and of certain neurodegenerative diseases. However, the possible role of the blood-brain barrier (BBB), the active interface between the blood circulation and brain tissue, remained unknown during these pathological conditions. In our in vitro reconstructed BBB model, 1-hr exposure of recombinant human TNF-alpha (in concentrations of 50, 250, and 500 U/ml, respectively) to the luminal membrane of bovine brain capillary endothelial cells (BBCEC) did not change significantly the transendothelial flux of either sucrose (m.w. 342 Da), or inulin (m.w. 5 kDa) up to 4 hr (early phase), except for a slight decrease (P < 0.05) in sucrose permeation at 2-4 hr with the highest dose of TNF-alpha. On the other hand, at 16 hr after the 1-hr challenge with TNF-alpha (delayed phase) at all 3 concentrations, significant increase was induced in the permeability of BBCEC monolayers for both markers. These changes of permeability were accompanied by a selective reorganization of F-actin filaments into stress fibers, while the intracellular distribution of vimentin remained similar to the control. These results suggest that BBCEC can respond directly to TNF-alpha by a delayed increase of permeability and reorganization of actin filaments.
Asunto(s)
Actinas/efectos de los fármacos , Encéfalo/efectos de los fármacos , Endotelio Vascular/efectos de los fármacos , Permeabilidad/efectos de los fármacos , Factor de Necrosis Tumoral alfa/farmacología , Animales , Astrocitos/efectos de los fármacos , Barrera Hematoencefálica , Bovinos , Células Cultivadas , Membranas/efectos de los fármacos , Microscopía Confocal , Sacarosa/metabolismo , Factores de TiempoRESUMEN
Lactoferrin (Lf) is an iron-binding protein involved in host defense against infection and severe inflammation; it accumulates in the brain during neurodegenerative disorders. Before determining Lf function in brain tissue, we investigated its origin and demonstrate here that it crosses the blood-brain barrier. An in vitro model of the blood-brain barrier was used to examine the mechanism of Lf transport to the brain. We report that differentiated bovine brain capillary endothelial cells exhibited specific high (Kd = 37.5 nM; n = 90,000/cell) and low (Kd = 2 microM; n = 900,000 sites/cell) affinity binding sites. Only the latter were present on nondifferentiated cells. The surface-bound Lf was internalized only by the differentiated cell population leading to the conclusion that Lf receptors were acquired during cell differentiation. A specific unidirectional transport then occurred via a receptor-mediated process with no apparent intraendothelial degradation. We further report that iron may cross the bovine brain capillary endothelial cells as a complex with Lf. Finally, we show that the low density lipoprotein receptor-related protein might be involved in this process because its specific antagonist, the receptor-associated protein, inhibits 70% of Lf transport.
Asunto(s)
Endocitosis , Lactoferrina/metabolismo , Animales , Membrana Basal/metabolismo , Barrera Hematoencefálica , Bovinos , Línea Celular , Endotelio Vascular/citología , Endotelio Vascular/metabolismo , Unión ProteicaRESUMEN
PURPOSE: The objective of this work was to assess, in vitro, the passage of P-glycoprotein dependent drugs across brain capillary endothelial cells, when these drugs are associated with a reversing agent. METHODS: An in vitro model of the blood-brain barrier consisting of a coculture of brain capillary endothelial cells and astrocytes was used. RESULTS: We demonstrate that P-glycoprotein expression is upregulated by the presence of astrocytes. Uptake in the cells and transport across endothelial cell monolayers of vincristine, cyclosporin A and doxorubicin were studied. Using S9788 or verapamil as reversing agents, we found an increase in vincristine transport across the endothelial cell monolayers. On the other hand, the association of S9788 or verapamil with cyclosporin A failed to increase the transport of this drug. An increase in the transport of doxorubicin from luminal to abluminal compartment was also observed, due to endothelial cell monolayer breakdown. CONCLUSIONS: Using this model, it is possible to predict the passage of a P-glycoprotein dependent drug to the brain or its sequestration in brain capillary endothelial cells when this drug is associated with a reversing agent, or its toxicity on the blood-brain barrier integrity.
Asunto(s)
Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/antagonistas & inhibidores , Antibióticos Antineoplásicos/farmacocinética , Antineoplásicos Fitogénicos/farmacocinética , Antineoplásicos/farmacología , Barrera Hematoencefálica/fisiología , Encéfalo/irrigación sanguínea , Ciclosporina/farmacocinética , Doxorrubicina/farmacocinética , Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/metabolismo , Inmunosupresores/farmacocinética , Piperidinas/farmacología , Triazinas/farmacología , Vincristina/farmacocinética , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/biosíntesis , Animales , Astrocitos/citología , Astrocitos/metabolismo , Transporte Biológico/efectos de los fármacos , Barrera Hematoencefálica/efectos de los fármacos , Encéfalo/metabolismo , Bloqueadores de los Canales de Calcio/farmacología , Bovinos , Técnicas de Cocultivo , Endotelio Vascular/citología , Valor Predictivo de las Pruebas , Ratas , Verapamilo/farmacologíaRESUMEN
Since endothelial cells (ECs) play a key role in immune defense mechanisms and in immunopathology, we investigated whether the intravascular helminth parasite Schistosoma mansoni could interact with and activate resting ECs in vitro. Microscopic analysis revealed that the lung-stage schistosomula specifically attached to microvascular ECs. This adherence was associated to active cellular processes involving actin filament formation. Since variation of permeability of cultured capillary brain ECs is a good marker for endothelial activation, the transendothelial passage of a low-molecular-weight molecule (inulin) on monolayers of bovine brain capillary ECs (BBCEC) was measured in response to parasites. Schistosomula induced a dramatic decrease in transendothelial permeability, a characteristic marker for the generation of an anti-inflammatory phenotype to ECs. This paracellular barrier enhancing effect on endothelial monolayers was due to a soluble substance(s) (below 1 kDa in size) secreted from S. mansoni schistosomula and not by mechanisms associated to adherence between parasites and ECs. The reinforcement of the endothelial barrier function was accompanied by an elevation of intracellular concentration of cyclic AMP (cAMP). The use of specific kinase inhibitors confirms that schistosomula activate ECs through a cAMP/protein kinase A pathway that leads to an increased phosphorylation of the myosin light-chain kinase. These combined findings suggest that the secretory/excretory products from schistosomula possess anti-inflammatory factor(s) that signal host microvascular endothelium. The immunological consequences of such activation are discussed.
Asunto(s)
Endotelio Vascular/fisiopatología , Endotelio Vascular/parasitología , Schistosoma mansoni/parasitología , Esquistosomiasis mansoni/parasitología , Animales , Permeabilidad Capilar , Bovinos , Comunicación Celular , Células Cultivadas , Inflamación , Schistosoma mansoni/fisiología , Esquistosomiasis mansoni/fisiopatología , Transducción de SeñalRESUMEN
Cyclophilin B (CyPB) is a cyclosporin A (CsA)-binding protein mainly located in intracellular vesicles and secreted in biological fluids. In previous works, we demonstrated that CyPB interacts with T lymphocytes and enhances in vitro cellular incorporation and activity of CsA. In addition to its immunosuppressive activity, CsA is able to promote regeneration of damaged peripheral nerves. However, the crossing of the drug from plasma to neural tissue is restricted by the relative impermeability of the blood-brain barrier. To know whether CyPB might also participate in the delivery of CsA into the brain, we have analyzed the interactions of CyPB with brain capillary endothelial cells. First, we demonstrated that CyPB binds to two types of binding sites present at the surface of capillary endothelial cells from various species of tissues. The first type of binding sites (K(D) = 300 nM; number of sites = 3 x 10(6)) is related to interactions with negatively charged compounds such as proteoglycans. The second type of binding sites, approximately 50,000 per cell, exhibits a higher affinity for CyPB (K(D) = 15 nM) and is involved in an endocytosis process, indicating it might correspond to a functional receptor. Finally, the use of an in vitro model of blood-brain barrier allowed us to demonstrate that CyPB is transcytosed by a receptor-mediated pathway (flux = 16.5 fmol/cm2/h). In these conditions, CyPB did not significantly modify the passage of CsA, indicating that it is unlikely to provide a pathway for CsA brain delivery.
Asunto(s)
Barrera Hematoencefálica/fisiología , Ciclofilinas , Endotelio Vascular/metabolismo , Inmunofilinas/metabolismo , Receptores de Péptidos/fisiología , Animales , Apéndice/irrigación sanguínea , Astrocitos/fisiología , Transporte Biológico , Encéfalo/irrigación sanguínea , Capilares , Bovinos , Línea Celular , Técnicas de Cocultivo , Ciclosporina/metabolismo , Humanos , Radioisótopos de Yodo , Cinética , Isomerasa de Peptidilprolil , Venas UmbilicalesRESUMEN
The passage of substances across the blood-brain barrier (BBB) is regulated in the cerebral capillaries, which possess certain distinct different morphological and enzymatic properties compared with the capillaries of other organs. Investigations of the functional characteristics of brain capillaries have been facilitated by the use of cultured brain endothelial cells, but in most studies some characteristics of the in vivo BBB are lost. To provide an in vitro system for studying brain capillary functions, we have developed a process of coculture that closely mimics the in vivo situation by culturing brain capillary endothelial cells on one side of a filter and astrocytes on the other. In order to assess the drug transport across the blood-brain barrier, we compared the extraction ratios in vivo to the permeability of the in vitro model. The in vivo and the in vitro values showed a strong correlation. The relative ease with which such cocultures can be produced in large quantities facilitates the screening of new centrally active drugs. This model provides an easier, reproducible and mass-production method to study the blood-brain barrier in vitro.